These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3909340)
21. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden. Norrby SR Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788 [TBL] [Abstract][Full Text] [Related]
22. Clinical experience with aztreonam in the treatment of gram-negative bacteremia. Scully BE; Henry SA Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of aztreonam in the treatment of severe bacterial infections. Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa. Conrad DA; Williams RR; Couchman TL; Lentnek AL Rev Infect Dis; 1991; 13 Suppl 7():S634-9. PubMed ID: 2068473 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections. Clergeot A; Steru D; Rosset MA; Carbon C J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924 [TBL] [Abstract][Full Text] [Related]
26. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients. Rabinad E; Bosch-Perez A Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288 [TBL] [Abstract][Full Text] [Related]
27. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections. Birolini D; Moraes MF; de Souza OS Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290 [TBL] [Abstract][Full Text] [Related]
28. Aztreonam: the first monobactam. Neu HC Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906 [TBL] [Abstract][Full Text] [Related]
29. Aztreonam in the treatment of gram-negative bacterial meningitis. Lentnek AL; Williams RR Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463 [TBL] [Abstract][Full Text] [Related]
30. Infections due to gram-negative bacteria: an overview. Neu HC Rev Infect Dis; 1985; 7 Suppl 4():S778-82. PubMed ID: 3909337 [TBL] [Abstract][Full Text] [Related]
32. Aztreonam in the therapy of severe gram-negative infections. Davies A; Stone J; Hassan A; Quarty P; Green T Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455 [No Abstract] [Full Text] [Related]
34. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. Marco V; Gobernado M; Santos M; Rabinad E Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295 [TBL] [Abstract][Full Text] [Related]
35. Clinical studies of aztreonam in Japan. Hara K; Kobayashi H; Nishiura T; Yura J; Saito A Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of aztreonam in the treatment of patients with renal failure. Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477 [TBL] [Abstract][Full Text] [Related]